Endothelin in neurohormonal activation in heart failure.
Boerrigter
Guido
G
Cardiorenal Research Laboratory, Mayo Clinic and Foundation, Rochester, Minnesota 55905, USA.
Burnett
John C
JC
D000818:Animals; D002264:Carboxylic Acids / Q000494:pharmacology / Q000627:therapeutic use; D065128:Endothelin Receptor Antagonists; D016232:Endothelins / Q000502:physiology*; D004730:Endothelium, Vascular / Q000502:physiology / Q000503:physiopathology; D006321:Heart / Q000187:drug effects; D006333:Heart Failure / Q000503:physiopathology*; D006801:Humans; D007189:Indans / Q000494:pharmacology / Q000627:therapeutic use; D018377:Neurotransmitter Agents / Q000502:physiology*; D011725:Pyridines / Q000494:pharmacology / Q000627:therapeutic use; D013777:Tetrazoles / Q000494:pharmacology / Q000627:therapeutic use; D014665:Vasodilator Agents / Q000494:pharmacology / Q000627:therapeutic use
D002264:Carboxylic Acids; D065128:Endothelin Receptor Antagonists; D016232:Endothelins; D007189:Indans; D018377:Neurotransmitter Agents; D011725:Pyridines; D013777:Tetrazoles; D014665:Vasodilator Agents; C120582:tezosentan; C098288:enrasentan